A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non–muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non–muscle-invasive bladder cancer

Published:2020-05 Issue:5 Volume:38 Page:433-439
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Sood Rajeev,Sharma Hitt,Sharma Bhuvaneshwari,Parekh Sameer,Pujari Pramod,Shewale Sunil

Funder

Serum Institute of India Pvt. Ltd.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference22 articles.

1. Intravesical instillation treatment of non‐muscle‐invasive bladder cancer;Braasch;Eur Urol Suppl,2009

2. Risk-adapted use of intravesical immunotherapy;Braasch;BJU Int,2008

3. Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer;Lamm;Clin Infect Dis,2000

4. Intravesical bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: a review;Saluja;Int J Urol,2018

5. Low-dose versus standard dose of bacillus Calmette-Guerin in the treatment of nonmuscle invasive bladder cancer: a systematic review and meta-analysis;Zeng;Medicine (Baltimore),2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and tolerability of bacillus Calmette-Guérin strain Russia for the treatment of non-muscle-invasive bladder cancer;Canadian Urological Association Journal;2024-03-01

2. Carcinoma In Situ (CIS): Is There a Difference in Efficacy between Various BCG Strains? A Comprehensive Review of the Literature;Cancers;2024-01-05

3. Comparison of hyperthermic intravesical chemotherapy and Bacillus Calmette–Guerin therapy in high-risk non-muscle invasive bladder cancer: a matched-pair analysis;International Urology and Nephrology;2023-10-25

4. The Impact of Dose Reduction of Bacillus Calmette–Guerin on Oncological Outcomes and Toxicity in Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis;Bladder Cancer;2023-09-25

5. Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis;Immunotherapy;2023-08